StockNews.AISignal intelligence

Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

ENVABullishM&AShort Term
High materiality8/10

Enova Reports Second Quarter 2026 Results

StockNews.AIJul 23, 4:16 PM EDT1 source
Trading thesisImportance 8/10

Buy ENVA on expected Grasshopper closing and synergy realization within 12 months.

AI summary

What happened and why it matters

Enova reported strong Q2 2026 results with revenue of $929 million, up 22% year over year, and EPS of $4.00, up 40% (adjusted EPS $4.31, up 33%). The company highlighted solid credit metrics and a 61% net revenue margin, while confirming the planned Grasshopper Bank acquisition to close later this year and deliver synergies. With liquidity at $929 million and a $19 million stock repurchase, Enova raised its full-year outlook as originations grew 27% and total loans rose to $5.5 billion (up 28%).

  • Grasshopper Bank acquisition expected to close later this year, potential upside.
  • Q2 metrics support raised full-year guidance and earnings visibility.
  • Stock buyback of $19M signals capital discipline and cash flow strength.
  • Robust credit metrics: 7.3% net charge-off ratio and 61% net revenue margin.

Sentiment rationale

Strong Q2 results, expansion of originations, higher full-year guidance, and a major acquisition synergy story typically lift multiple valuations and attract buyers; near-term catalysts include Grasshopper closing and potential further margin expansion.

Key facts

  1. 01

    ENVA Q2 2026 revenue $929M, up 22% YoY; originations +27%.

  2. 02

    Diluted EPS $4.00, up 40%; adjusted EPS $4.31, up 33%.

  3. 03

    Net revenue margin at 61% vs 58% YoY; credit performance strong.

  4. 04

    Announces planned Grasshopper Bank acquisition; closing later this year.

  5. 05

    Liquidity $929M; repurchased $19M of stock; balance sheet remains robust.

M&A

Category: M&A. The primary driver is the strategic Grasshopper Bank acquisition; earnings and health metrics support valuation upside, but regulatory risk remains a factor.